M19.21 M75.1
Conditions
Interventions
Group 1: satisfying result 6 and 24 months postoperatively (score of the American Society of Shoulder and Elbow Surgery <= 76)
shoulder function is assessed with scores
perfusion is assessed with contrast-enhanced ultrasound at both points in time.
Group 2: unsatisfying result 6 and 24 months postoperatively (score of the American Society of Shoulder and Elbow Surger
perfusion is assessed with contrast-enhanced ultrasound at both points in time.
Group 3: Subjects without any shoulder complaints
perfusion is assessed with contrast-enhanced ultrasound
Sponsors
Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM) e.V.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with the indication for a reverse shoulder arthroplasty; healthy subjects
Exclusion criteria
Exclusion criteria: - known intolerance for SonoVue - severe heart failure (NYHA III/IV) - myocardial infarction within the last 14 days - severe respiratory diseases - pregnancy and breastfeeding - age under 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder function: Constant-Murley-, ASES-, DASH-Score, Simple Shoulder Test; Psychosocial outcome: SF-12; Pain: visual analogue scale; 6 and 24 months postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Development of the perfusion in deltoid muscle tissue, assessed with contrast-enhanced ultrasound; 6 and 24 months postoperatively | — |
Countries
Germany
Contacts
Public ContactChristian Alexander Fischer
Universitätsklinikum Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Outcome results
None listed